Wearing Face Mask Reduces Risk for Symptoms of Respiratory Infection
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 31, 2024 -- Wearing a surgical mask in public spaces is associated with a reduced risk for self-reported symptoms consistent with a respiratory infection, according to a study published online July 24 in The BMJ.
Runar Barstad Solberg, Ph.D., from the Norwegian Institute of Public Health in Oslo, and colleagues conducted a pragmatic randomized superiority trial involving 4,647 adults to assess the personal protective effects of wearing versus not wearing surgical face masks in public spaces on self-reported respiratory symptoms. Participants were assigned to an intervention arm (2,371 participants) or control arm (2,276 participants); the intervention arm was assigned to wear a surgical face mask in public spaces during a 14-day period.
The researchers identified 163 events of self-reported symptoms consistent with respiratory infection reported in the intervention arm and 239 events in the control arm (8.9 versus 12.2 percent), with a marginal odds ratio of 0.71 favoring the face mask intervention (absolute risk difference, −3.2 percent). No significant effect was seen in terms of self-reported or registered COVID-19 infection.
"The effect size was moderate, but wearing a face mask is a simple intervention with low burden and of relatively low cost and is one of several public health and social measures that may be worth considering for reducing the spread of respiratory infections," the authors write.
One author is named inventor on a patent application related to vaccine development.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis
TUESDAY, May 20, 2025 -- For patients with pulmonary sarcoidosis, methotrexate is noninferior to prednisone with regard to the change from baseline to week 24 in the percentage of...
Use of Composite Allocation Score for Lung Transplant Wait List Improves Outcomes
MONDAY, May 19, 2025 -- Wait-list outcomes for lung transplants have substantially improved in the composite allocation score (CAS) era, according to a study presented at the...
Medicaid Unwinding Linked to Disruption of Chronic Medication Therapy in Youth
FRIDAY, May 16, 2025 -- In young patients, especially young adults, Medicaid unwinding associated with the COVID-19 pandemic disrupted chronic medication therapy, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.